Delivery Order 36C24821D0025-36C24824N0349
Award Date 2/1/24
Potential Completion Date 1/31/25
Potential Value $148K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Port Chester, NY 10573, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $710,168.17 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 21, to Cytopath Biopsy Lab Inc. (operating as Cblpath) for the ThyroSeq V3 Classifier CPT molecular diagnostic testing service. The contract has an ultimate completion date of August 4, 2029 and exercises the first option year. This award is not associated with a set-aside program. Cytopath Biopsy Lab Inc. is a for-profit organization...
- This federal contract award is for a Blanket Purchase Agreement (BPA) call with Cytopath Biopsy Lab Inc., operating as Cblpath, to provide the U.S. Department of Veterans Affairs (VA) with the company's proprietary ThyroSeq molecular diagnostic testing services. The $100,000.00 firm-fixed-price contract has a period of performance through September 30, 2026 and supports cancer screening and diagnosis programs for veterans. Cytopath Biopsy Lab Inc. is a for-profit organization specializing in...
- This is a federal contract award to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for $78,750.00 to provide ThyroSeq genomic testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type, awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 6. The contract is for the ultimate completion date of September 30, 2026. Cytopath Biopsy Lab Inc. is a for-profit organization...
- This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a regional healthcare network within the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The $200,000.00 contract is for the provision of ThyroSeq genetic testing services to support cancer screening and diagnosis for veterans. ThyroSeq is a molecular diagnostic test that evaluates genetic mutations to assess the malignancy of thyroid...
- This federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the delivery of ThyroSeq molecular diagnostic testing services. The $4,200.00 firm fixed price contract was issued by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12, to support cancer screening and diagnosis programs for veterans. The contract is not set aside and references Cytopath Biopsy Lab Inc.'s prior work providing ThyroSeq genetic testing for...
- This is a federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of specialized thyroid cancer diagnostic testing services to the U.S. Department of Veterans Affairs (VA). The contract, valued at $10,000.00, is a Blanket Purchase Agreement (BPA) call order issued under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. Cytopath Biopsy Lab Inc. will deliver its ThyroSeq molecular diagnostic testing services to support cancer...
- This federal contract award is for $78,750.00 to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for THYROSEQ GENOMIC TESTING services. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 6 (VISN 6). The contract has an ultimate completion date of September 30, 2026 and was awarded on October 1, 2025. Cytopath Biopsy Lab Inc. is...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq laboratory tests to determine thyroid nodule malignancy for surgical decision making. The $72,000.00 award is part of an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle between the VA and Cytopath Biopsy Lab Inc. to support cancer screening and diagnosis programs within the VA healthcare network. The contract...
- This is a federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSequence Testing Services to the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price pricing type, with a total ceiling value of $120,000.00 and a period of performance through February 12, 2028. This award is not set aside and is likely part of a larger Indefinite Delivery/Indefinite Quantity...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a $288,000 firm fixed-price delivery order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on February 1, 2025, for ThyroSeq molecular diagnostic testing services. The contract, which has no set-aside designation, is scheduled for completion by January 31, 2026, with services to be performed in Port Chester, New York. ThyroSeq is a proprietary genetic testing service that analyzes mutations in thyroid...